AI Medical Technology

aliveseries-b
series-b
Stage
1
Investors

About

AI Medical Technology develops AI-powered diagnostic solutions to assist healthcare practitioners in making faster, easier, and more reliable diagnoses. Their first product, Dermalyser, is a decision support tool for skin cancer diagnosis undergoing clinical validation.

Explore AI Medical Technology's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.